10x Genomics TXG
NASDAQ TXG
$90.04 +1.54 (+1.74%)
At close: Sep 29, 2026 · 4:00 PM EDT

10x Genomics (TXG) Receivables - Other (2024 - 2026)

Updated

10x Genomics (TXG) recorded Receivables - Other of $3.08 million in Q2 2026, down 95.5% from $69.09 million a year earlier and down 82.0% from the prior quarter.

Analysis

10x Genomics (TXG) Receivables - Other (2024 - 2026) Analysis & Trends

At the end of FY2025, 10x Genomics reported Receivables - Other of $35.48 million.

  • Across earlier years, Receivables - Other came in at $606,000 in FY2024.
  • The Q2 2026 figure is the lowest quarterly Receivables - Other since Q4 2024.
  • Per Business Quant, the preceding three quarters came in at $17.11 million (Q1 2026), $35.48 million (Q4 2025) and $52.81 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 250.84 Bn 229.99 Bn 4.88 Bn
2 Abbott Laboratories 174.73 Bn 145.82 Bn 7.27 Bn
3 Danaher 159.85 Bn 143.67 Bn 3.61 Bn
4 Intuitive Surgical 146.79 Bn 126.35 Bn 1.96 Bn
5 Medtronic 114.54 Bn 80.41 Bn 6.34 Bn
6 Stryker 105.67 Bn 91.79 Bn 4.50 Bn
7 Boston Scientific 63.93 Bn 58.94 Bn 3.85 Bn
8 Becton Dickinson 50.12 Bn 47.27 Bn 2.32 Bn
9 Edwards Lifesciences 50.06 Bn 34.17 Bn 1.35 Bn
10 10x Genomics 11.53 Bn 11.33 Bn 112.50 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 3.08 Mn
Mar 31, 2026 17.11 Mn
Dec 31, 2025 35.48 Mn
Sep 30, 2025 52.81 Mn
Jun 30, 2025 69.09 Mn
Dec 31, 2024 606,000.00
API Access

10x Genomics Receivables - Other API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables-other&ticker=TXG&period=max&api_key=YOUR_API_KEY